QualityStocks would like to highlight International Stem Cell Corporation (http://www.qualitystocks.net/stocks1.html">OTCBB: ISCO), focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs).
In the company’s news,
International Stem Cell Corp. announced that $1 million has been invested by a number of existing long-standing investors through a private placement on the same terms as the transaction with management reported on January 22, 2013.
The funds, along with those received in January 2013 from members of the management team, will help advance ISCO’s therapeutic programs towards clinical stage, building upon recently announced promising pre-clinical data for both the Parkinson’s and Liver disease programs.
“To have a number of existing shareholders increase their positions is gratifying and shows a high level of confidence in our ability to deliver milestones and build shareholder value,” stated Dr. Andrey Semechkin, CEO and Co-Chairman of ISCO. “It is very important to us that we have the trust of some of our largest shareholders and that they have a strong belief in both management’s ability to execute and the technical, medical and immunological advantages of human parthenogenetic stem cells.”
“We believe passionately that hpSC will play an important part in the development of treatments for a number of incurable diseases and this investment brings this vision closer to reality,” Dr. Semechkin concluded.
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.